MYD88 and asthma: This study explored the inhibitory effect of MUC1 on NLRP3 inflammasome-mediated pyroptosis in patients with asthma and revealed that one of the underlying mechanisms is the downregulation of TLR4/MyD88/NF-κB pathway activation.